WEDNESDAY, SEPTEMBER 28, 2022
8:00 a.m.
Welcome and introduction of Jay Van Andel Award honoree
8:10 a.m.
Jay Van Andel Award for Outstanding Achievement in Parkinson’s Disease Research lecture
9:10 a.m.
Discussion
9:25 a.m.
Break
Session 1: Mitochondrial function in Parkinson’s disease
9:40 a.m.
J. Timothy Greenamyre, M.D., Ph.D. – Pittsburgh Institute for Neurodegenerative Diseases, University of Pittsburgh
10:10 a.m.
Oliver Bandmann, M.D., Ph.D. – Sheffield Institute for Translational Neuroscience
10:40 a.m.
Matt Klein, M.D., M.S., FACS – PTC Therapeutics
11:10 a.m.
Abstract Selected Talk
11:25 a.m.
Discussion
11:40 a.m.
Lunch
Session 2: GLP-1 Agonists
1:00 p.m.
Nigel Greig, Ph.D. – National institute on Aging, National Institutes of Health
1:30 p.m.
Wassilios Meissner, M.D., Ph.D., FEAN – University Hospital Bordeaux
2:00 p.m.
Michele Tagliati, M.D., FAAN – Cedar-Sinai Medical Center
2:30 p.m.
Discussion
2:45 p.m.
Break
Session 3: c-Abl Inhibition
3:00 p.m.
Milton Werner, Ph.D. – Inhibikase Therapeutics, Inc.
3:30 p.m.
Tanya Simuni, M.D., FAAN – Northwestern University Feinberg School of Medicine
4:00 p.m.
Phillippe Damier, M.D., Ph.D., FEAN – University of Nantes
4:25 p.m.
Abstract Selected Talk
4:40 p.m.
Discussion
5:00 – 7:30 p.m.
Poster session and dinner
THURSDAY, SEPTEMBER 29, 2022
Session 4: Alpha-synuclein
8:00 a.m.
Tiago Outeiro, Ph.D. – University Medical Center Goettingen
8:30 a.m.
Speaker TBD
9:00 a.m.
Elpida Tsika, Ph.D. – AC Immune SA (invited)
9:25 a.m.
Abstract Selected Talk
9:40 a.m.
Discussion
10:00 a.m.
Break
Session 5: Neuroinflammation
10:15 a.m.
Ashley Harms, Ph.D. – UAB | The University of Alabama at Birmingham
10:45 a.m.
David Standaert, M.D., Ph.D. – UAB | The University of Alabama at Birmingham
11:15 a.m.
Speaker TBD
11:45 a.m.
Abstract Selected Talk
12:00 p.m.
Discussion
12:15 p.m.
Lunch
Tom Isaacs Award Presentation
1:30 p.m
Tom Isaacs Award Presentation
1:45 p.m.
Report from the Rallying to the Challenge Meeting
Session 6: Lysosomal Targets
2:15 p.m.
Lena Burbulla, Ph.D. – Biomedical Center, LMU Munich
2:45 p.m.
Judy Peterschmitt, Ph.D. – Sanofi
3:15 p.m.
Speaker TBD
3:45 p.m.
Discussion
4:00 p.m.
Closing remarks